Drugs / Carbidopa/Levodopa
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06596876 Comparator | Nov 2024 → Oct 2025 | Parkinson disease | Jiangsu HengRui Medicine Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Carbidopa/Levodopa | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06596876 ↗ |
| Route | Oral | “administered orally” NCT06596876 ↗ |